Aramark (ARMK) director Patricia Lopez receives 5,124 deferred stock units

Rhea-AI Filing Summary

Aramark director Patricia E. Lopez reported an equity award of 5,124 deferred stock units of common stock on February 3, 2026. The units are valued at $38.06 per share for reporting purposes, and her directly held beneficial ownership increased to 28,992.516 shares after this grant.

The deferred stock units will vest on the day before the first annual stockholders’ meeting of Aramark that occurs after the grant date, as long as she continues serving on the board. Once vested, they will be settled in Aramark common stock on the first day of the seventh month after she leaves the board.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider LOPEZ PATRICIA E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,124	$38.06	$195K

Holdings After Transaction: Common Stock — 28,992.516 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LOPEZ PATRICIA E

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/03/2026		A		5,124(1)	A	$38.06	28,992.516	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) report for Patricia E. Lopez?

Aramark reported that director Patricia E. Lopez received a grant of 5,124 deferred stock units of common stock. These units are a form of equity compensation that will convert into Aramark shares after vesting and her departure from the board.

What is the vesting schedule for Patricia E. Lopez’s new Aramark (ARMK) stock units?

The 5,124 deferred stock units granted to Patricia E. Lopez will vest on the day before the first annual stockholders’ meeting following the grant date, subject to her continued board service, and will be settled in common shares months after she leaves the board.

How many Aramark (ARMK) shares does Patricia E. Lopez own after this Form 4 transaction?

After the reported grant, Patricia E. Lopez beneficially owns 28,992.516 shares of Aramark common stock directly. This figure reflects her holdings following the addition of 5,124 deferred stock units reported in the latest insider transaction filing.

What was the reported price for Patricia E. Lopez’s Aramark (ARMK) stock unit grant?

The 5,124 deferred stock units were reported at a price of $38.06 per share for Form 4 disclosure purposes. This price is an accounting value used to describe the grant, not necessarily a cash transaction purchase price in the open market.

Is Patricia E. Lopez considered a director or officer of Aramark (ARMK) in this filing?

In this Form 4, Patricia E. Lopez is identified as a director of Aramark and not as an officer or 10% owner. The equity award reflects typical non-employee director compensation structured as deferred stock units.